Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Expert Opinion on Therapeutic Targets|January 31, 2003
Apoptosis in the myocardium: much is still expectedSamuil R Umansky, L David TomeiFrontiers in Cellular Neuroscience|September 24, 2013
Circulating cell-free microRNA as biomarkers for screening, diagnosis and monitoring of neurodegenerative diseases and other neurologic pathologiesKira S Sheinerman, Samuil R UmanskyExpert Review of Molecular Diagnostics|March 4, 2006
Transrenal DNA testing: progress and perspectivesSamuil R Umansky, L David TomeiJournal of Translational Medicine|December 17, 2013
Analysis of organ-enriched microRNAs in plasma as an approach to development of Universal Screening Test: feasibility studyKira S Sheinerman, Vladimir G Tsivinsky, Samuil R UmanskyPlos One|July 11, 2019
Brain-enriched microRNAs circulating in plasma as novel biomarkers for Rett syndromeKira Sheinerman, Aleksandra Djukic, Vladimir G Tsivinsky, et al.Methods in Molecular Biology (Clifton, N.J.)|August 19, 2006
Novel applications of polymerase chain reaction to urinary nucleic acid analysisAnatoly V Lichtenstein, Hovsep S Melkonyan, L David Tomei, et al.Aging|December 26, 2013
Plasma microRNA biomarkers for detection of mild cognitive impairment: biomarker validation studyKira S Sheinerman, Vladimir G Tsivinsky, Laila Abdullah, et al.Aging|September 25, 2012
Plasma microRNA biomarkers for detection of mild cognitive impairmentKira S Sheinerman, Vladimir G Tsivinsky, Fiona Crawford, et al.Clinical Chemistry|February 3, 2009
Optimization of transrenal DNA analysis: detection of fetal DNA in maternal urineEugene M Shekhtman, Kalpana Anne, Hovsep S Melkonyan, et al.Annals of the New York Academy of Sciences|October 8, 2008
Transrenal nucleic acids: from proof of principle to clinical testsHovsep S Melkonyan, W John Feaver, Erik Meyer, et al.Pageof 2